Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1.38a
Percent of AMI patients who received recommended hospital care,a Medicare beneficiaries, United States, 2002 and 2004
    2004 2002
Population group Percent Standard error Percent Standard error
Total 85.6 0.2 80.0 0.2
Gender Male 86.1 0.2 81.1 0.2
Female 84.9 0.2 78.6 0.2
Race White 86.0 0.2 80.5 0.2
Black 82.7 0.6 76.5 0.6
Hispanic 80.2 1.1 71.4 1.2
Native American 85.5 1.6 80.0 1.9
Asian 80.0 1.5 79.7 1.5
Age Under 65 85.7 0.4 DNA DNA
65-74 87.0 0.2 DNA DNA
75-84 85.5 0.3 DNA DNA
85 and over 83.2 0.4 DNA DNA

a Recommended hospital care for AMI includes administrations of aspirin and beta-blocker within 24 hours of hospital arrival and at discharge, receiving a prescription of angiotensin converting enzyme (ACE) inhibitor at discharge for patients with left ventricular systolic dysfunction, and giving smoking cessation counseling for smoking patients.

DNA - Data have not been analyzed.

Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.

Return to Contents

 

AHRQ Advancing Excellence in Health Care